Widely used:Recently Viewed
Clear All
$17.29
$0.46
(2.73%)
As on 17-Apr-2025 16:19EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$682 Mln
P/E Ratio
35.06
P/B Ratio
2.76
Industry P/E
37.44
Debt to Equity
2.99
ROE
0.07 %
ROCE
--
Div. Yield
2.85 %
Book Value
6.09
EPS
0.48
CFO
$473.40 Mln
EBITDA
$923.95 Mln
Net Profit
$493.80 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Phibronimal Health Corporation Class A (PAHC)
| -17.67 | -18.64 | -17.39 | 33.10 | -4.03 | -5.44 | -6.60 |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Phibronimal Health Corporation Class A (PAHC)
| 80.47 | -13.65 | -34.33 | 5.15 | -21.79 | -22.79 | -3.98 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 59.17 | 11,278.97 | 26.62 | 8.05 | |
| 62.24 | 6,815.49 | 52.52 | 23.56 | |
| 58.21 | 11,313.41 | 389.73 | 0.76 | |
| 7.56 | 8,821.37 | -- | -3.24 |
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance... Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Address: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 Read more
Chairman, President & CEO
Mr. Jack Clifford Bendheim
Chairman, President & CEO
Mr. Jack Clifford Bendheim
Headquarters
Teaneck, NJ
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Phibro Animal Health Corporation Class A (PAHC) stood at $ 1,519 Mln as on 31-Dec-24
The share price of Phibro Animal Health Corporation Class A (PAHC) is $17.29 (NASDAQ) as of 17-Apr-2025 16:19 EDT. Phibro Animal Health Corporation Class A (PAHC) has given a return of -4.03% in the last 3 years.
Phibro Animal Health Corporation Class A (PAHC) has a market capitalisation of $ 682 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Phibro Animal Health Corporation Class A (PAHC) is 2.76 times as on 17-Apr-2025, a 45% discount to its peers’ median range of 5.04 times.
The P/E ratio of Phibro Animal Health Corporation Class A (PAHC) is 35.06 times as on 17-Apr-2025, a 6% discount to its peers’ median range of 37.44 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Phibro Animal Health Corporation Class A (PAHC) and enter the required number of quantities and click on buy to purchase the shares of Phibro Animal Health Corporation Class A (PAHC).
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Address: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712
The CEO & director of Mr. Jack Clifford Bendheim. is Phibro Animal Health Corporation Class A (PAHC), and CFO & Sr. VP is Mr. Jack Clifford Bendheim.
There is no promoter pledging in Phibro Animal Health Corporation Class A (PAHC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,131
|
|
|
1,128
|
|
|
882
|
|
|
682
|
| Phibro Animal Health Corporation Class A (PAHC) | Ratios |
|---|---|
|
Return on equity(%)
|
7.67
|
|
Operating margin(%)
|
6.19
|
|
Net Margin(%)
|
1.75
|
|
Dividend yield(%)
|
2.85
|
No, TTM profit after tax of Phibro Animal Health Corporation Class A (PAHC) was $0 Mln.
